These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S; Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274 [TBL] [Abstract][Full Text] [Related]
8. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis. Lee CH; Mamelak AJ; Vonderheid EC Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344 [TBL] [Abstract][Full Text] [Related]
9. A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T-cell lymphoma, responding to extracorporeal photopheresis. Kreuter A; Hoffmamm K; Altmeyer P J Am Acad Dermatol; 2005 Apr; 52(4):706-8. PubMed ID: 15793532 [No Abstract] [Full Text] [Related]
10. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ; Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088 [TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649 [TBL] [Abstract][Full Text] [Related]
12. Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma. Zackheim HS J Am Acad Dermatol; 2000 Jun; 42(6):1087-8. PubMed ID: 10827420 [No Abstract] [Full Text] [Related]
13. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma. Fimiani M; Rubegni P; D'Ascenzo G; Andreassi L J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):828-30. PubMed ID: 7929941 [No Abstract] [Full Text] [Related]
14. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma. Geskin L Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808 [TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photochemotherapy in long-term treatment of early stage cutaneous T-cell lymphoma. Rubegni P; De Aloe G; Fimiani M Br J Dermatol; 2000 Oct; 143(4):894-6. PubMed ID: 11069483 [No Abstract] [Full Text] [Related]
17. New insights into the mechanism of action of extracorporeal phototherapy. Moss FM Transfusion; 2006 Jan; 46(1):6-8. PubMed ID: 16398723 [No Abstract] [Full Text] [Related]
18. Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis. Demierre MF; Ferzli P; Miller D Arch Dermatol; 2007 May; 143(5):659-61. PubMed ID: 17515522 [No Abstract] [Full Text] [Related]